Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-522-0 | CAS number: 61-90-5
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 293.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 10
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 2 935 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- No adverse effects were observed during the test. The NOAEL is based on max. tested concentration.
- AF for differences in duration of exposure:
- 2
- Justification:
- NOAEL from 90d study: subchronic to chronic extrapolation, REACH guidance AF value.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Only differences not related to calorimetric differences are to be taken into account. Calorimetric differences are taken into account during route-to-route extrapolation.
- AF for other interspecies differences:
- 1
- Justification:
- See discussion section below.
- AF for intraspecies differences:
- 5
- Justification:
- REACH Guidance AF value.
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance AF value.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 833 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 33 300 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- No adverse effects were observed during the test. The NOAEL is based on max. tested concentration.
- AF for differences in duration of exposure:
- 2
- Justification:
- NOAEL from 90d study: subchronic to chronic extrapolation, REACH guidance AF value.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance AF value for calorimetric differences between rat and human.
- AF for other interspecies differences:
- 1
- Justification:
- See discussion section below.
- AF for intraspecies differences:
- 5
- Justification:
- REACH Guidance AF value.
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance AF value.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The additional assessment factor 2.5 for "remaining interspecies differences" was not used for the following reasons:
"The factor of 2.5 accounts for other interspecies differences in toxicokinetics (not related to metabolic rate) and toxicodynamics. Absorption, Distribution, Metabolism as well as Excretion of proteinogenic amino acids are very similar between animals (mammals) and humans: These amino acids are taken up via the oral route by animals as well as humans by generally the same mechanisms (or/and are build endogenously).Regardless of whether they enter the intestinal cells as peptides or amino acids they enter the hepatic portal circulation as single amino acids. Absorbed amino acids leave the hepatic portal system and enter the peripheral blood. These amino acids are taken up by tissues for synthesis of cellular proteins and other physiologically active compounds in animals and humans. Degradation involves removal of the amino group, which in mammals is converted to urea and excreted in the urine. After removal of the amino group the rest of the acid is utilised as energy or used to synthesize other endogenous substances. Also with regard to toxicodynamics (however real toxic effects of amino acids in humans as well as in animals are hardly detectable even at high doses) there is no obvious difference between mammals and humans."
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 72.4 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 20
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 448 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- No adverse effects were observed during the test. The NOAEL is based on max. tested concentration.
- AF for differences in duration of exposure:
- 2
- Justification:
- NOAEL from 90d study: subchronic to chronic extrapolation, REACH guidance AF value.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Only differences not related to calorimetric differences are to be taken into account. Calorimetric differences are taken into account during route-to-route extrapolation.
- AF for other interspecies differences:
- 1
- Justification:
- See discussion section below.
- AF for intraspecies differences:
- 10
- Justification:
- REACH Guidance AF value.
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance AF value.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 416 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 33 300 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- No adverse effects were observed during the test. The NOAEL is based on max. tested concentration.
- AF for differences in duration of exposure:
- 2
- Justification:
- NOAEL from 90d study: subchronic to chronic extrapolation, REACH guidance AF value.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance AF value for calorimetric differences between rat and human.
- AF for other interspecies differences:
- 1
- Justification:
- See discussion section below.
- AF for intraspecies differences:
- 10
- Justification:
- REACH Guidance AF.
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance AF.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 41.6 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 3 330 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- No adverse effects were observed during the test. The NOAEL is based on max. tested concentration.
- AF for differences in duration of exposure:
- 2
- Justification:
- NOAEL from 90d study: subchronic to chronic extrapolation, REACH guidance AF value.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance AF value for calorimetric differences between rat and human.
- AF for other interspecies differences:
- 1
- Justification:
- See discussion section below.
- AF for intraspecies differences:
- 10
- Justification:
- REACH Guidance AF.
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance AF.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The additional assessment factor 2.5 for "remaining interspecies differences" was not used for the following reasons:
"The factor of 2.5 accounts for other interspecies differences in toxicokinetics (not related to metabolic rate) and toxicodynamics. Absorption, Distribution, Metabolism as well as Excretion of proteinogenic amino acids are very similar between animals (mammals) and humans: These amino acids are taken up via the oral route by animals as well as humans by generally the same mechanisms (or/and are build endogenously).Regardless of whether they enter the intestinal cells as peptides or amino acids they enter the hepatic portal circulation as single amino acids. Absorbed amino acids leave the hepatic portal system and enter the peripheral blood. These amino acids are taken up by tissues for synthesis of cellular proteins and other physiologically active compounds in animals and humans. Degradation involves removal of the amino group, which in mammals is converted to urea and excreted in the urine. After removal of the amino group the rest of the acid is utilised as energy or used to synthesize other endogenous substances. Also with regard to toxicodynamics (however real toxic effects of amino acids in humans as well as in animals are hardly detectable even at high doses) there is no obvious difference between mammals and humans."
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
